Cero Therapeutics Files 2024 Annual Report
Ticker: CEROW · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1870404
Sentiment: neutral
Topics: annual-report, biotech, sec-filing
TL;DR
Cero Therapeutics filed its 2024 10-K. Formerly Phoenix Biotech.
AI Summary
Cero Therapeutics Holdings, Inc. filed its annual report for the fiscal year ended December 31, 2024. The company, formerly known as Phoenix Biotech Acquisition Corp. until June 30, 2021, is incorporated in Delaware and headquartered in South San Francisco, California. Cero Therapeutics operates in the biological products sector, specifically focusing on products excluding diagnostics.
Why It Matters
This filing provides a comprehensive overview of Cero Therapeutics' financial performance and business operations for the past fiscal year, offering insights for investors and stakeholders.
Risk Assessment
Risk Level: low — This is a standard annual report filing and does not inherently present new risks.
Key Numbers
- 001-40877 — Commission File Number (Identifies the company's filing with the SEC)
- 81-4182129 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- CERO THERAPEUTICS HOLDINGS, INC. (company) — Registrant
- 2024 (date) — Fiscal year end
- December 31 (date) — Fiscal year end
- Phoenix Biotech Acquisition Corp. (company) — Former company name
- 20210630 (date) — Date of name change
- Delaware (jurisdiction) — State of incorporation
- South San Francisco, CA (location) — Principal executive offices
- 201 Haskins Way, Suite 230 (address) — Principal executive offices
FAQ
What is the primary business of Cero Therapeutics Holdings, Inc.?
Cero Therapeutics Holdings, Inc. is engaged in the biological products sector, specifically excluding diagnostic substances, as indicated by its SIC code [2836].
When did Cero Therapeutics Holdings, Inc. change its name from Phoenix Biotech Acquisition Corp.?
The company changed its name from Phoenix Biotech Acquisition Corp. on June 30, 2021.
Where are Cero Therapeutics Holdings, Inc.'s principal executive offices located?
The principal executive offices are located at 201 Haskins Way, Suite 230, South San Francisco, CA 94080.
What is the filing date of this 10-K report?
This 10-K report was filed on April 15, 2025.
For which fiscal year is this annual report filed?
This annual report is filed for the fiscal year ended December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding CERO THERAPEUTICS HOLDINGS, INC. (CEROW).